Collaboration Agreements And Business Development Activities - GSK (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 30, 2022 |
Dec. 31, 2021 |
Jan. 01, 2021 |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Collaboration agreement percent of royalty on net sale | 3.00% | ||
Collaborative Arrangements with GSK and Royalty Pharma | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Royalty expense | $ 58.2 | $ 46.6 | $ 32.7 |